Characteristics of 1196 patients with a detectable HCV-RNA, according to HCV-treatment status (patients under HCV treatment at the time of analysis and patients with HCV reinfection excluded).

CDC: Centers for Disease Control; IQR: interquartile range; ART: antiretroviral treatment; NRTI: nucleoside/nucleotide reverse transcriptase inhibitor; bPI: ritonavir-boosted protease inhibitor; NNRTI: non-nucleoside reverse transcriptase inhibitor; INSTI: integrase strand transfer inhibitor.* Creatinine clearance estimated using the Cockcroft-Gault Equation: creatinine clearance = (140 –age (years)) / weight (kg) * 1.23 (male) or * 1.04 (female)Characteristics of 1196 patients with a detectable HCV-RNA, according to HCV-treatment status (patients under HCV treatment at the time of analysis and patients with HCV reinfection excluded).

本数据集涉及以下专业缩写及对应释义：CDC（Centers for Disease Control，美国疾病预防控制中心）、IQR（interquartile range，四分位距）、ART（antiretroviral treatment，抗逆转录病毒治疗）、NRTI（nucleoside/nucleotide reverse transcriptase inhibitor，核苷/核苷酸逆转录酶抑制剂）、bPI（ritonavir-boosted protease inhibitor，利托那韦增强型蛋白酶抑制剂）、NNRTI（non-nucleoside reverse transcriptase inhibitor，非核苷逆转录酶抑制剂）、INSTI（integrase strand transfer inhibitor，整合酶链转移抑制剂）。采用科克罗夫特-高特公式（Cockcroft-Gault Equation）估算肌酐清除率，计算公式为：肌酐清除率 = (140 – 年龄（岁）) / 体重（kg） × 1.23（男性）或 × 1.04（女性）。本研究纳入1196例HCV-RNA可检测的患者，按HCV治疗状态分析其临床特征，且已排除分析时点正在接受HCV治疗的患者与HCV再感染患者。